Benralizumab in severe eosinophilic asthma: a comprehensive systematic review and meta-analysis of randomized controlled trials evaluating lung function, asthma control, and safety outcomes
Abbas Al Mutair, Yasmine Alabbasi, Hanan F. Alharbi, Hanan Alyami, Haifa Mohmmed Al-Shammari, Abdullah Awad Al-Omari, Eman A. Bomozah, Faiza Aljarameez, Muhammad Daniyal · 2026
Read Benralizumab in severe eosinophilic asthma: a comprehensive systematic review and meta-analysis of randomized controlled trials evaluating lung function, asthma control, and safety outcomes by Abbas Al Mutair, Yasmine Alabbasi, Hanan F. Alharbi, Hanan Alyami, Haifa Mohmmed Al-Shammari, Abdullah Awad Al-Omari, Eman A. Bomozah, Faiza Aljarameez, Muhammad Daniyal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13445655.txt.
Description
Abbas Al Mutair and colleagues present a 2026 systematic review and meta-analysis of benralizumab, an antibody that blocks an interleukin-5 receptor to cut eosinophils, for severe eosinophilic asthma. The team pooled 15 randomized trials covering 5,502 patients, with 3,061 on the drug and 2,441 on placebo, tracking lung function, symptom control, and safety.
The drug improved lung capacity by about 0.11 liters on average and significantly improved symptom control scores, while adverse event odds did not differ from placebo. Gains fell under the bar for a minimal clinically important difference on control scores, and heterogeneity ran high. The treatment offers a small but real gain for heavily obstructed patients, with individual response varying.
Catalog record
| CREATOR | Abbas Al Mutair, Yasmine Alabbasi, Hanan F. Alharbi, Hanan Alyami, Haifa Mohmmed Al-Shammari, Abdullah Awad Al-Omari, Eman A. Bomozah, Faiza Aljarameez, Muhammad Daniyal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |